| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteins | 11 | 2019 | 140 | 3.460 |
Why?
|
| Cysteine | 17 | 2019 | 131 | 3.350 |
Why?
|
| Sulfenic Acids | 11 | 2019 | 52 | 2.990 |
Why?
|
| Oxidation-Reduction | 21 | 2019 | 250 | 2.190 |
Why?
|
| Head and Neck Neoplasms | 4 | 2017 | 117 | 1.920 |
Why?
|
| Sulfhydryl Compounds | 4 | 2015 | 33 | 1.600 |
Why?
|
| Radiation Tolerance | 4 | 2019 | 22 | 1.570 |
Why?
|
| Mass Spectrometry | 7 | 2019 | 99 | 1.380 |
Why?
|
| Mitochondria | 6 | 2019 | 174 | 1.110 |
Why?
|
| Oxidative Stress | 7 | 2019 | 223 | 1.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 8 | 2014 | 34 | 0.970 |
Why?
|
| Staining and Labeling | 4 | 2018 | 56 | 0.870 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 69 | 0.830 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2018 | 72 | 0.830 |
Why?
|
| Molecular Probes | 3 | 2019 | 15 | 0.820 |
Why?
|
| Mitochondrial Proteins | 2 | 2019 | 67 | 0.780 |
Why?
|
| Peroxiredoxins | 5 | 2018 | 106 | 0.770 |
Why?
|
| Reactive Oxygen Species | 6 | 2018 | 158 | 0.710 |
Why?
|
| Animals | 23 | 2019 | 7297 | 0.680 |
Why?
|
| Humans | 46 | 2019 | 29093 | 0.670 |
Why?
|
| Indicators and Reagents | 1 | 2018 | 15 | 0.650 |
Why?
|
| Quinazolines | 2 | 2018 | 31 | 0.650 |
Why?
|
| Cytological Techniques | 1 | 2018 | 19 | 0.650 |
Why?
|
| Kinetics | 16 | 2017 | 205 | 0.640 |
Why?
|
| Sulfones | 1 | 2017 | 14 | 0.620 |
Why?
|
| Phenols | 1 | 2017 | 16 | 0.620 |
Why?
|
| Drug Discovery | 1 | 2017 | 30 | 0.610 |
Why?
|
| Tetrazoles | 1 | 2017 | 71 | 0.610 |
Why?
|
| Chondrocytes | 4 | 2019 | 71 | 0.590 |
Why?
|
| DNA Damage | 2 | 2014 | 88 | 0.590 |
Why?
|
| Bacterial Proteins | 6 | 2013 | 77 | 0.580 |
Why?
|
| Protein Isoforms | 3 | 2012 | 56 | 0.530 |
Why?
|
| 3-Deoxy-7-Phosphoheptulonate Synthase | 2 | 2005 | 2 | 0.520 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2015 | 7 | 0.520 |
Why?
|
| Cyclin D2 | 1 | 2015 | 7 | 0.520 |
Why?
|
| Hydrogen Peroxide | 5 | 2019 | 81 | 0.510 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2011 | 13 | 0.510 |
Why?
|
| Peptide Fragments | 4 | 2016 | 422 | 0.510 |
Why?
|
| Signal Transduction | 9 | 2019 | 666 | 0.500 |
Why?
|
| Mice | 13 | 2019 | 2368 | 0.500 |
Why?
|
| Models, Molecular | 12 | 2018 | 178 | 0.500 |
Why?
|
| Aldehyde-Lyases | 4 | 2010 | 5 | 0.500 |
Why?
|
| Cells | 1 | 2014 | 4 | 0.490 |
Why?
|
| Nucleic Acids | 1 | 2014 | 6 | 0.490 |
Why?
|
| Dithiothreitol | 1 | 2013 | 8 | 0.480 |
Why?
|
| Energy Metabolism | 1 | 2015 | 139 | 0.480 |
Why?
|
| DNA Methylation | 1 | 2015 | 130 | 0.480 |
Why?
|
| Cartilage, Articular | 3 | 2019 | 68 | 0.460 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 142 | 0.440 |
Why?
|
| Cell Cycle | 2 | 2017 | 69 | 0.440 |
Why?
|
| Lipids | 1 | 2014 | 209 | 0.440 |
Why?
|
| Neoplasms | 2 | 2019 | 610 | 0.420 |
Why?
|
| Ketone Oxidoreductases | 2 | 2002 | 3 | 0.420 |
Why?
|
| Radiation, Ionizing | 4 | 2019 | 22 | 0.410 |
Why?
|
| Cyclopentanes | 1 | 2011 | 17 | 0.410 |
Why?
|
| Phosphotransferases (Phosphomutases) | 4 | 2013 | 4 | 0.400 |
Why?
|
| Escherichia coli | 4 | 2010 | 82 | 0.390 |
Why?
|
| Fibroblasts | 1 | 2011 | 103 | 0.390 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2009 | 10 | 0.370 |
Why?
|
| Sulfinic Acids | 2 | 2013 | 11 | 0.360 |
Why?
|
| Phosphoenolpyruvate | 3 | 2010 | 4 | 0.360 |
Why?
|
| Phosphorylation | 6 | 2019 | 225 | 0.350 |
Why?
|
| NIH 3T3 Cells | 4 | 2014 | 43 | 0.340 |
Why?
|
| Phosphoglucomutase | 4 | 2013 | 5 | 0.340 |
Why?
|
| Aging | 4 | 2017 | 881 | 0.340 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 680 | 0.330 |
Why?
|
| Escherichia coli Proteins | 2 | 2005 | 31 | 0.330 |
Why?
|
| Oxidoreductases | 1 | 2008 | 20 | 0.330 |
Why?
|
| Antioxidants | 2 | 2019 | 114 | 0.310 |
Why?
|
| Coenzyme A | 2 | 2009 | 4 | 0.310 |
Why?
|
| Sulfur | 2 | 2009 | 4 | 0.310 |
Why?
|
| Amino Acid Sequence | 7 | 2018 | 280 | 0.310 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 2019 | 15 | 0.310 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 50 | 0.300 |
Why?
|
| Chlamydia trachomatis | 2 | 2019 | 6 | 0.300 |
Why?
|
| Glucose | 3 | 2017 | 163 | 0.290 |
Why?
|
| Troponin T | 2 | 2017 | 57 | 0.280 |
Why?
|
| Cell Survival | 3 | 2017 | 272 | 0.260 |
Why?
|
| Osteoarthritis | 2 | 2016 | 74 | 0.260 |
Why?
|
| Salmonella typhimurium | 3 | 2015 | 33 | 0.250 |
Why?
|
| Biocatalysis | 5 | 2015 | 19 | 0.250 |
Why?
|
| Cell Line | 4 | 2016 | 449 | 0.250 |
Why?
|
| Cyclohexanones | 3 | 2016 | 17 | 0.250 |
Why?
|
| Binding Sites | 7 | 2015 | 125 | 0.250 |
Why?
|
| Molecular Structure | 4 | 2019 | 53 | 0.250 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 350 | 0.230 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 494 | 0.220 |
Why?
|
| Models, Biological | 3 | 2017 | 373 | 0.220 |
Why?
|
| Mutation | 6 | 2013 | 466 | 0.210 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2019 | 60 | 0.210 |
Why?
|
| Iron | 1 | 2002 | 113 | 0.210 |
Why?
|
| Oxidants | 2 | 2019 | 15 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2013 | 73 | 0.200 |
Why?
|
| Catalytic Domain | 6 | 2018 | 58 | 0.200 |
Why?
|
| Acetyl Coenzyme A | 1 | 2000 | 1 | 0.190 |
Why?
|
| Pyruvic Acid | 1 | 2000 | 5 | 0.190 |
Why?
|
| Clostridium | 1 | 2000 | 6 | 0.190 |
Why?
|
| Carbon Dioxide | 1 | 2000 | 36 | 0.190 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2017 | 29 | 0.190 |
Why?
|
| Computational Biology | 2 | 2017 | 86 | 0.180 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 14 | 0.180 |
Why?
|
| Pyruvate Synthase | 3 | 2006 | 3 | 0.180 |
Why?
|
| Hindlimb Suspension | 1 | 2019 | 11 | 0.170 |
Why?
|
| Sirtuin 2 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Isothiocyanates | 1 | 2019 | 6 | 0.170 |
Why?
|
| Complement C3 | 1 | 2019 | 7 | 0.170 |
Why?
|
| Space Flight | 1 | 2019 | 19 | 0.170 |
Why?
|
| Chlamydia Infections | 1 | 2019 | 5 | 0.170 |
Why?
|
| Complement Activation | 1 | 2019 | 10 | 0.170 |
Why?
|
| NAD | 1 | 2019 | 25 | 0.170 |
Why?
|
| Organophosphorus Compounds | 1 | 2019 | 35 | 0.170 |
Why?
|
| Serpins | 1 | 2018 | 6 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 5 | 2012 | 95 | 0.170 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 18 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 37 | 0.170 |
Why?
|
| Penile Erection | 1 | 2018 | 16 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 4 | 0.170 |
Why?
|
| Receptors, Cholinergic | 1 | 2018 | 21 | 0.170 |
Why?
|
| Urine | 1 | 2019 | 59 | 0.170 |
Why?
|
| Sympathetic Nervous System | 1 | 2018 | 29 | 0.170 |
Why?
|
| Acetylcholine | 1 | 2018 | 47 | 0.170 |
Why?
|
| Coordination Complexes | 1 | 2018 | 6 | 0.170 |
Why?
|
| Eye Proteins | 1 | 2018 | 33 | 0.170 |
Why?
|
| Penis | 1 | 2018 | 33 | 0.170 |
Why?
|
| Platinum | 1 | 2018 | 19 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 87 | 0.160 |
Why?
|
| Organoplatinum Compounds | 1 | 2018 | 42 | 0.160 |
Why?
|
| Hip Joint | 1 | 2019 | 57 | 0.160 |
Why?
|
| Protein Stability | 2 | 2016 | 26 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 51 | 0.160 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2015 | 27 | 0.160 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 37 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2013 | 27 | 0.160 |
Why?
|
| Lung Injury | 1 | 2018 | 64 | 0.160 |
Why?
|
| Knee Joint | 1 | 2019 | 129 | 0.160 |
Why?
|
| Naphthoquinones | 1 | 2017 | 3 | 0.160 |
Why?
|
| NADP | 1 | 2017 | 9 | 0.160 |
Why?
|
| Sulfhydryl Reagents | 1 | 2017 | 5 | 0.160 |
Why?
|
| Sirtuins | 1 | 2017 | 19 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 212 | 0.150 |
Why?
|
| Crystallography, X-Ray | 5 | 2018 | 77 | 0.150 |
Why?
|
| Bacteria | 2 | 2010 | 45 | 0.150 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 195 | 0.150 |
Why?
|
| Models, Genetic | 1 | 2017 | 92 | 0.150 |
Why?
|
| Substrate Specificity | 4 | 2015 | 84 | 0.150 |
Why?
|
| Sepsis | 1 | 2019 | 146 | 0.150 |
Why?
|
| Muscle Denervation | 1 | 2017 | 28 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2017 | 97 | 0.150 |
Why?
|
| Homeostasis | 1 | 2017 | 127 | 0.150 |
Why?
|
| Stem Cells | 1 | 2019 | 292 | 0.140 |
Why?
|
| Nitrites | 1 | 2016 | 20 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2019 | 799 | 0.140 |
Why?
|
| Monocytes | 1 | 2017 | 119 | 0.140 |
Why?
|
| Catalysis | 5 | 2009 | 64 | 0.140 |
Why?
|
| Erythrocytes | 1 | 2016 | 43 | 0.140 |
Why?
|
| Calpain | 1 | 2016 | 12 | 0.140 |
Why?
|
| Acyl Coenzyme A | 1 | 2015 | 4 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 2016 | 16 | 0.140 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 45 | 0.140 |
Why?
|
| Pancreas | 1 | 2016 | 79 | 0.140 |
Why?
|
| Nitric Oxide | 1 | 2016 | 116 | 0.130 |
Why?
|
| Silver | 1 | 2015 | 8 | 0.130 |
Why?
|
| Inflammation | 1 | 2019 | 507 | 0.130 |
Why?
|
| Oxygen | 1 | 2016 | 139 | 0.130 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 14 | 0.130 |
Why?
|
| Glycolysis | 1 | 2015 | 19 | 0.130 |
Why?
|
| Protein Binding | 4 | 2018 | 199 | 0.130 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 7 | 0.130 |
Why?
|
| CpG Islands | 1 | 2015 | 44 | 0.130 |
Why?
|
| Azacitidine | 1 | 2015 | 28 | 0.130 |
Why?
|
| Peptide Mapping | 1 | 2014 | 2 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 42 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 30 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 226 | 0.130 |
Why?
|
| Cycloparaffins | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 39 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 158 | 0.120 |
Why?
|
| Methyl Methanesulfonate | 1 | 2013 | 3 | 0.120 |
Why?
|
| Ethylmaleimide | 1 | 2013 | 6 | 0.120 |
Why?
|
| Iodoacetamide | 1 | 2013 | 7 | 0.120 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 21 | 0.120 |
Why?
|
| Protein Engineering | 2 | 2015 | 17 | 0.120 |
Why?
|
| Apolipoproteins | 1 | 2015 | 196 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 249 | 0.120 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 247 | 0.110 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 386 | 0.110 |
Why?
|
| Time Factors | 4 | 2019 | 2001 | 0.110 |
Why?
|
| Cadmium | 2 | 2010 | 8 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 5 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2012 | 13 | 0.110 |
Why?
|
| Nitroglycerin | 1 | 2012 | 11 | 0.110 |
Why?
|
| Esters | 1 | 2012 | 9 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 36 | 0.110 |
Why?
|
| Ketones | 1 | 2012 | 7 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2012 | 47 | 0.110 |
Why?
|
| Amino Acids | 1 | 2012 | 41 | 0.110 |
Why?
|
| Phenotype | 1 | 2014 | 629 | 0.110 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 31 | 0.110 |
Why?
|
| G1 Phase | 1 | 2011 | 8 | 0.100 |
Why?
|
| S Phase | 1 | 2011 | 11 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2014 | 173 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 86 | 0.100 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 5 | 0.100 |
Why?
|
| Acidosis | 1 | 2011 | 16 | 0.100 |
Why?
|
| DNA Primers | 1 | 2011 | 87 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2011 | 34 | 0.100 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2011 | 20 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 711 | 0.100 |
Why?
|
| Models, Chemical | 2 | 2008 | 30 | 0.100 |
Why?
|
| Base Sequence | 1 | 2011 | 240 | 0.100 |
Why?
|
| Tissue Engineering | 1 | 2016 | 608 | 0.100 |
Why?
|
| Cell Movement | 1 | 2011 | 161 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 481 | 0.100 |
Why?
|
| Proteomics | 3 | 2017 | 92 | 0.090 |
Why?
|
| Phosphines | 1 | 2010 | 3 | 0.090 |
Why?
|
| S-Nitrosoglutathione | 1 | 2010 | 4 | 0.090 |
Why?
|
| S-Nitrosothiols | 1 | 2010 | 5 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 16 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 546 | 0.090 |
Why?
|
| Pentosephosphates | 2 | 2010 | 2 | 0.090 |
Why?
|
| Thiosulfate Sulfurtransferase | 1 | 2009 | 2 | 0.090 |
Why?
|
| Flavins | 1 | 2009 | 5 | 0.090 |
Why?
|
| Bacillus anthracis | 1 | 2009 | 9 | 0.090 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 10 | 0.090 |
Why?
|
| Biosensing Techniques | 1 | 2010 | 20 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 66 | 0.090 |
Why?
|
| Point Mutation | 1 | 2009 | 23 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 666 | 0.090 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2008 | 5 | 0.080 |
Why?
|
| Glutathione | 1 | 2008 | 37 | 0.080 |
Why?
|
| African Americans | 1 | 2015 | 1373 | 0.080 |
Why?
|
| Vitamin K 3 | 2 | 2019 | 6 | 0.080 |
Why?
|
| Neuromuscular Junction | 2 | 2018 | 67 | 0.080 |
Why?
|
| Fibronectins | 2 | 2018 | 34 | 0.080 |
Why?
|
| Apoptosis | 2 | 2019 | 337 | 0.080 |
Why?
|
| Kidney | 1 | 2011 | 485 | 0.070 |
Why?
|
| Hela Cells | 2 | 2019 | 78 | 0.070 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 113 | 0.070 |
Why?
|
| Female | 7 | 2019 | 18164 | 0.070 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2006 | 10 | 0.070 |
Why?
|
| Thiamine Pyrophosphate | 1 | 2006 | 4 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2006 | 42 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2017 | 105 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 573 | 0.070 |
Why?
|
| Sugar Phosphates | 1 | 2005 | 1 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2005 | 21 | 0.070 |
Why?
|
| Muscular Atrophy | 2 | 2018 | 67 | 0.070 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 20 | 0.070 |
Why?
|
| Circular Dichroism | 2 | 2017 | 30 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 93 | 0.070 |
Why?
|
| Zinc Compounds | 1 | 2004 | 4 | 0.060 |
Why?
|
| Deuterium | 1 | 2004 | 9 | 0.060 |
Why?
|
| Chlorides | 1 | 2004 | 15 | 0.060 |
Why?
|
| Thermodynamics | 2 | 2017 | 45 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2015 | 85 | 0.060 |
Why?
|
| Nitrosation | 2 | 2016 | 4 | 0.060 |
Why?
|
| Middle Aged | 4 | 2019 | 10829 | 0.060 |
Why?
|
| Bacteria, Anaerobic | 1 | 2002 | 3 | 0.060 |
Why?
|
| Electron Transport | 1 | 2002 | 16 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 248 | 0.060 |
Why?
|
| Databases, Protein | 2 | 2012 | 13 | 0.050 |
Why?
|
| Disulfides | 2 | 2013 | 34 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 980 | 0.050 |
Why?
|
| Sulfur Compounds | 2 | 2012 | 6 | 0.050 |
Why?
|
| Ferredoxins | 1 | 2000 | 1 | 0.050 |
Why?
|
| Male | 4 | 2018 | 17807 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 33 | 0.040 |
Why?
|
| Telomerase | 1 | 2019 | 21 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 71 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2019 | 22 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 22 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 40 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2019 | 76 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 16 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 8420 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 171 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2018 | 17 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2018 | 37 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 23 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2019 | 281 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2018 | 53 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 67 | 0.040 |
Why?
|
| Contusions | 1 | 2018 | 41 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 143 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 77 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 67 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 200 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.040 |
Why?
|
| Nucleotides | 1 | 2017 | 16 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2017 | 21 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 82 | 0.040 |
Why?
|
| Organogenesis | 1 | 2016 | 15 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 233 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2017 | 114 | 0.040 |
Why?
|
| Leucine | 1 | 2016 | 24 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 747 | 0.040 |
Why?
|
| Action Potentials | 1 | 2017 | 174 | 0.040 |
Why?
|
| Isometric Contraction | 1 | 2016 | 21 | 0.040 |
Why?
|
| Muscle Fatigue | 1 | 2016 | 11 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 17 | 0.040 |
Why?
|
| Catalase | 1 | 2016 | 16 | 0.040 |
Why?
|
| History, Ancient | 1 | 2016 | 6 | 0.040 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2016 | 20 | 0.040 |
Why?
|
| Acyl Carrier Protein | 1 | 2015 | 3 | 0.030 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2015 | 3 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2015 | 7 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 10 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 50 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 45 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2015 | 40 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 38 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 40 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 73 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 30 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 62 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 74 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2016 | 65 | 0.030 |
Why?
|
| Vasodilation | 1 | 2016 | 87 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 148 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 136 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 249 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 167 | 0.030 |
Why?
|
| Aged | 2 | 2019 | 9487 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2015 | 251 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1108 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 859 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 126 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 21 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2015 | 239 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 35 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 40 | 0.030 |
Why?
|
| Glucose-6-Phosphate | 1 | 2012 | 1 | 0.030 |
Why?
|
| Nitrates | 1 | 2012 | 25 | 0.030 |
Why?
|
| Isoflavones | 1 | 2012 | 65 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 84 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 836 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 2011 | 9 | 0.030 |
Why?
|
| Obesity | 1 | 2019 | 1063 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 18 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2011 | 11 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 104 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 89 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 18 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2009 | 9 | 0.020 |
Why?
|
| Crystallization | 1 | 2009 | 16 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 63 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 514 | 0.020 |
Why?
|
| Tyrosine | 1 | 2009 | 22 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 462 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 8 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 82 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Rhodamines | 1 | 2007 | 4 | 0.020 |
Why?
|
| Biotin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cyclohexenes | 1 | 2007 | 12 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2007 | 24 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 3717 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3531 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2009 | 143 | 0.020 |
Why?
|
| Time | 1 | 2005 | 21 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2004 | 8 | 0.020 |
Why?
|
| Ions | 1 | 2004 | 11 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2004 | 21 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2004 | 17 | 0.020 |
Why?
|
| Magnesium | 1 | 2004 | 22 | 0.020 |
Why?
|
| Plasmids | 1 | 2004 | 48 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 74 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 641 | 0.010 |
Why?
|